Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00959985 | Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer | terminated | N/A | 23 | Massachusetts General HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01853436 | Impact of ADM in Reduction of Surgical Complexity of Breast Reconstructions With Implants (Nava) | terminated | N/A | 36 | LifeCellINDUSTRY | 1 | May 25, 2017 | clinicaltrials |
| NCT02322853 |
| A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors(OLYMPE) |
| terminated |
| Phase 2 |
| 8 |
| Centre Francois BaclesseOTHER |
| 1 |
| May 24, 2017 |
| clinicaltrials |
| NCT00324324 | Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant | terminated | Phase 3 | 240 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00900068 | Blood Samples From Patients on a Clinical Trial to CINV During HSCT | terminated | — | 9 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02483377 | Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer | terminated | — | 13 | University of Southern CaliforniaOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT02217033 | Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo | terminated | N/A | 16 | South Sound Care FoundationOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT02370264 | Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer | terminated | N/A | 36 | University of Southern CaliforniaOTHER | 1 | Apr 13, 2017 | clinicaltrials |
| NCT00661531 | Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy | terminated | Phase 2 | 11 | Georgetown UniversityOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01151449 | Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Apr 11, 2017 | clinicaltrials |
| NCT01729884 | Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer | terminated | Phase 2 | 3 | University of WashingtonOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT00126451 | A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) | terminated | Phase 2 | 16 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 10, 2017 | clinicaltrials |
| NCT01110954 | Fluorescence-guided Resection in Breast Cancer | terminated | Phase 2 | 8 | photonamic GmbH & Co. KGINDUSTRY | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00179634 | Study of Fine Art Photographs and Visualization Tapes to Improve Surgical Recovery in Breast Cancer | terminated | N/A | 24 | Beth Israel Deaconess Medical CenterOTHER | 1 | Mar 24, 2017 | clinicaltrials |
| NCT00176488 | Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | terminated | Phase 2 | 31 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00549822 | Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer | terminated | Phase 2 | 3 | Massachusetts General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT00496366 | Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer | terminated | Phase 2 | 11 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT00263211 | A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients | terminated | Phase 2 | 48 | Washington University School of MedicineOTHER | 1 | Mar 15, 2017 | clinicaltrials |
| NCT00285857 | Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention | terminated | Phase 2 | 30 | Stanford UniversityOTHER | 1 | Mar 9, 2017 | clinicaltrials |
| NCT02144012 | A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer | terminated | Phase 3 | 49 | Hoffmann-La RocheINDUSTRY | 4 | Mar 7, 2017 | clinicaltrials |
| NCT01120158 | Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer | terminated | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01562873 | Ruxolitinib in Patients With Breast Cancer | terminated | Phase 2 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00904423 | Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption | terminated | Phase 1 / Phase 2 | 8 | Mark PegramOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT00133796 | Neoadjuvant Herceptin in Patients With Breast Cancer | terminated | Phase 2 | 40 | Mothaffar RimawiOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00481845 | Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer | terminated | Phase 2 | 1 | Stanford UniversityOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01856036 | Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers | terminated | N/A | 2 | Saint John's Cancer InstituteOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00087620 | A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer | terminated | Phase 4 | — | Hoffmann-La RocheINDUSTRY | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00946283 | Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome | terminated | N/A | 30 | Rutgers, The State University of New JerseyOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT02273752 | Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer | terminated | Phase 2 | 2 | Emory UniversityOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00301106 | Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver | terminated | Phase 1 | 2 | Max SungOTHER | 1 | Feb 2, 2017 | clinicaltrials |
| NCT01699672 | Group-based or Individual Information About Disease and Treatment Plan | terminated | N/A | 98 | Norwegian University of Science and TechnologyOTHER | 1 | Jan 26, 2017 | clinicaltrials |
| NCT00537173 | Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer | terminated | — | 11 | Hoosier Cancer Research NetworkOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT00282529 | Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study | terminated | N/A | 400 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT00096109 | Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2017 | clinicaltrials |
| NCT00045591 | Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer | terminated | Phase 2 | 39 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT02213744 | MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients(HERMIONE) | terminated | Phase 2 / Phase 3 | 113 | Merrimack PharmaceuticalsINDUSTRY | 9 | Jan 6, 2017 | clinicaltrials |
| NCT01708798 | Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer | terminated | Phase 2 / Phase 3 | 44 | University of British ColumbiaOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT01167192 | Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer | terminated | Phase 2 | 10 | Washington University School of MedicineOTHER | 1 | Dec 30, 2016 | clinicaltrials |
| NCT00752986 | ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial(ZACFAST) | terminated | Phase 2 | 39 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT00912444 | Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer(NATT) | terminated | Phase 3 | 102 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 22, 2016 | clinicaltrials |
| NCT01875198 | Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer | terminated | N/A | 1 | Yonsei UniversityOTHER | 1 | Nov 22, 2016 | clinicaltrials |
| NCT00977379 | A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis(XERAD) | terminated | Phase 2 | 24 | Hoffmann-La RocheINDUSTRY | 1 | Nov 15, 2016 | clinicaltrials |
| NCT01246726 | Multiple Oncological Serial Scans Study(MOSS) | terminated | N/A | 9 | University Hospitals Bristol and Weston NHS Foundation TrustOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT01609920 | Nodal Staging in Breast Cancer With MRL | terminated | N/A | 97 | Maastricht University Medical CenterOTHER | 1 | Nov 10, 2016 | clinicaltrials |
| NCT02197949 | Preoperative and Intraoperative Quantification of Axillary Tumoral Load | terminated | — | 12 | Parc de Salut MarOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02655159 | Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice(AMBER) | terminated | — | 46 | Celgene CorporationINDUSTRY | 1 | Nov 1, 2016 | clinicaltrials |
| NCT00066807 | Premenopausal Endocrine Responsive Chemotherapy Trial(PERCHE) | terminated | Phase 3 | 29 | ETOP IBCSG Partners FoundationNETWORK | 3 | Oct 28, 2016 | clinicaltrials |
| NCT02380209 | An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer | terminated | Early Phase 1 | 8 | University of ArizonaOTHER | 1 | Oct 27, 2016 | clinicaltrials |
Data updated 23 days agoSource updated May 30, 2017source: clinicaltrials